PAG
WINT

Pinnacle Advisory Group’s Windtree Therapeutics Inc WINT Stock Holding History

Pinnacle Advisory Group’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,939
Closed -$8K – 126
2015
Q4 		$8K Buy
2,939
+803
+38% +$3.29K ﹤0.01% 112
2015
Q3 		$8K Buy
2,136
+355
+20% +$2.35K ﹤0.01% 105
2015
Q2 		$16K Buy
1,781
+202
+13% +$2.84K ﹤0.01% 110
2015
Q1 		$26K Buy
1,579
+270
+21% +$5.32K ﹤0.01% 143
2014
Q4 		$21K Buy
1,309
+181
+16% +$3.98K ﹤0.01% 149
2014
Q3 		$29K Buy
1,128
+176
+18% +$4.25K ﹤0.01% 132
2014
Q2 		$23K Buy
952
+145
+18% +$3.71K ﹤0.01% 121
2014
Q1 		$24K Buy
+807
New +$27.2K ﹤0.01% 106

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Advisory Group's WINT Position: Q1 2016 in Review

Pinnacle Advisory Group sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 2,939 shares — an estimated $8K sold.

Pinnacle Advisory Group first reported a position in WINT in Q1 2014 and held it in 8 quarters. The position peaked at $29K in Q3 2014. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • Pinnacle Advisory Group reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • Pinnacle Advisory Group sold 2,939 Windtree Therapeutics Inc shares in Q1 2016, an estimated $8K.
  • Pinnacle Advisory Group first reported a position in Windtree Therapeutics Inc in Q1 2014 and held it in 8 quarters.
  • Pinnacle Advisory Group's Windtree Therapeutics Inc position peaked at $29K in Q3 2014.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Pinnacle Advisory Group's 13F filing for Q1 2016, filed 15 Apr 2016.